| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 41.782 | 46.263 | 55.809 | 71.827 | 85.314 | 96.943 | 136.860 | 69.422 | 29.298 | 34.581 |
| Total Income - EUR | 41.782 | 46.263 | 61.488 | 202.954 | 85.314 | 98.431 | 136.860 | 69.422 | 29.447 | 56.670 |
| Total Expenses - EUR | 12.386 | 14.322 | 19.818 | 148.512 | 11.861 | 8.122 | 8.051 | 4.440 | 7.257 | 55.912 |
| Gross Profit/Loss - EUR | 29.395 | 31.942 | 41.670 | 54.442 | 73.454 | 90.309 | 128.809 | 64.982 | 22.191 | 758 |
| Net Profit/Loss - EUR | 28.142 | 30.788 | 41.055 | 52.413 | 72.600 | 89.391 | 127.440 | 64.288 | 21.896 | 637 |
| Employees | 2 | 3 | 2 | 3 | 3 | 4 | 4 | 4 | 1 | 4 |
Check the financial reports for the company - Uropromed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 27.269 | 21.166 | 142.698 | 41.211 | 37.253 | 39.776 | 38.894 | 39.014 | 247.945 | 189.296 |
| Current Assets | 38.286 | 29.552 | 21.661 | 61.982 | 80.067 | 87.653 | 193.083 | 67.471 | 5.471 | 18.940 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 10.760 | 0 | 0 | 13.093 |
| Receivables | 1.060 | 956 | 181 | 0 | 39.162 | 21.976 | 4.125 | 61.939 | 1.345 | 804 |
| Cash | 37.226 | 28.596 | 21.480 | 61.982 | 40.905 | 65.677 | 178.197 | 5.532 | 4.126 | 5.043 |
| Shareholders Funds | 63.184 | 47.011 | 74.136 | 52.456 | 72.769 | 89.556 | 191.561 | 64.450 | 26.199 | 26.689 |
| Social Capital | 45 | 45 | 44 | 43 | 169 | 165 | 162 | 162 | 162 | 161 |
| Debts | 2.371 | 3.707 | 90.223 | 50.737 | 44.551 | 37.873 | 40.416 | 42.036 | 46.090 | 18.914 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 194.125 | 177.914 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Uropromed Srl